Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.

A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.

Elazer Edelman, M.D., Ph.D., a pioneer in the application of engineering and physical sciences to understand fundamental biological processes and the mechanisms of disease, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 5.

Stanley Hazen, M.D., Ph.D., chair of the Department of Cellular and Molecular Medicine at the Cleveland Clinic Lerner Research Institute, will present the ninth annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 5.

Kaz de Jong, Ph.D., a clinical psychologist with Doctors Without Borders, will discuss the mental health challenges of caring for people traumatized by war during a special lecture at the Vanderbilt Nursing Annex on Monday, Nov. 2.

There’s a little bit of Peru in the Department of Cell and Developmental Biology.